Other Headlines

Former Trade Desk pro from Siemens joins the DOTmed 100 company.
Gary Lee of DMS Topline Medical took some time to sit down with DOTmed News during the recent North Carolina Biomedical Association (NCBA).
The Canadian maker of high-end interventional MR suites acquires a prototype neurosurgery robot designed with aerospace technology in exchange for 1.6 million shares.
Two Idaho clinics are the latest to install NovaRad's NovaPACS to improve workflow and ease image access for interpreting and referring physicians.
The Institute of Cancer Research has found that women with breast cancer had more manageable side effects when their radiotherapy was delivered in larger - but fewer - doses.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More Industry Headlines

New Research Study Will Use fMRIs to Examine Soldiers' TBIs Research on traumatic brain injury will be used to determine faster treatment, safer vehicles.

Sebelius Wants Justification for Anthem Blue Cross' Premium Hike HHS Secretary and California Insurance Commissioner ask for details on costs and benefits.

Congress Submits Bill to Repeal Antitrust Exemption Reform measure would end exemption for health care, medical malpractice insurance.

FDA Issues Guidance on Facilitating Medical Device Clinical Trials Agency suggests statistical methods for cost and streamlining.

White House to Convene Health Meeting President Obama promised a bipartisan event Feb. 25.

Las Vegas Spine Surgeon Pleads Guilty to Misprision of Felony A federal case review from the pages of DOTmed Business News.

Philips Inks Three-Year Deal With SunCrest Philips' telemedicine division inked a three-year deal with the Sun Belt home care system SunCrest Healthcare, Inc.

Colorado Physicians Group Settles With FTC Over Alleged Price-Fixing Group accused of anti-competitive tactics against health insurers.

HHS Highlights Health Care Investments in New Budget Budget includes health IT, research, public health measures.

FDA Wants $4 Billion to Overhaul Medical Device, Food Safety Monitoring The injections of new cash could help establish a registry for medical devices and create over 1,000 new jobs.

UCSB researcher Les Wilson

Scientists Show How Cruciferous Veggies Stop Breast Cancer

by Lynn Shapiro, Writer
While it has been known for some time that eating cruciferous vegetables, such as broccoli, cauliflower, and cabbage, can help prevent breast cancer, the mechanism by which the active substances in these vegetables inhibit cell proliferation was unknown -- until now.

Scientists in the UC Santa Barbara laboratories of Leslie Wilson, professor of biochemistry and pharmacology, and Mary Ann Jordan, adjunct professor in the Department of Molecular, Cellular, and Developmental Biology, have shown how the healing power of these vegetables works at the cellular level. Their research is published in this month's issue of the journal Carcinogenesis.

"Breast cancer, the second leading cause of cancer death in women, can be protected against by eating cruciferous vegetables such as cabbage and near relatives of cabbage such as broccoli and cauliflower," said first author Olga Azarenko, who is a graduate student at UCSB. "These vegetables contain compounds called isothiocyanates which we believe to be responsible for the cancer-preventive and anti-carcinogenic activities in these vegetables. Broccoli and broccoli sprouts have the highest amount of the isothiocyanates.

"Our paper focuses on the anti-cancer activity of one of these compounds, called sulforaphane, or SFN," Azarenko added. "It has already been shown to reduce the incidence and rate of chemically induced mammary tumors in animals. It inhibits the growth of cultured human breast cancer cells, leading to cell death."

Azarenko made the surprising discovery that SFN inhibits the proliferation of human tumor cells by a mechanism similar to the way that the anticancer drugs taxol and vincristine inhibit cell division during mitosis. (Mitosis is the process in which the duplicated DNA in the form of chromosomes is accurately distributed to the two daughter cells when a cell divides.)

Hundreds of tiny tube-like structures, called microtubules, make up the machinery that cells use to separate the chromosomes. SFN, like the more powerful anticancer agents, interferes with microtubule functioning during mitosis in a similar manner to the more powerful anticancer drugs. However SFN is much weaker than these other plant-based drugs, and thus much less toxic.

"SFN may be an effective cancer preventive agent because it inhibits the proliferation and kills precancerous cells," said Wilson. It is also possible that it could be used as an addition to taxol and other similar drugs to increase effective killing of tumor cells without increased toxicity, Wilson said.


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2010 DOTmed.com, Inc.
ALL RIGHTS RESERVED